Tissue transglutaminase expression promotes castration-resistant phenotype and transcriptional repression of androgen receptor.

Abstract excerpt

Many studies have supported a role for inflammation in prostate tumour growth. However, the contribution of inflammation to the development of castration-resistant prostate cancer remains largely unknown. Based on observations that aberrant expression of the proinflammatory protein tissue transglutaminase (TG2) is associated with development of drug resistance and metastatic phenotype in multiple cancer types, we...

Topics

Share this publication in a Topic to start or enrich a Post.

• Share to Epithelial-Mesenchymal Transition
• Share to GTP-Binding Proteins